Acumen Pharmaceuticals(us:ABOS)

    1.77

    -4.32%

    Updated on 2024-12-23

    Open:1.85
    Close:1.77
    High:1.85
    Low:1.76
    Pre Close:1.85
    Volume:549509.00
    Amount:980352.56
    Turnover:-
    Shares:
    MarketCap:0.00
    DateTotalTotal SharesTotal RatioNewIncreasedDecreased
    2024-06-301024355873072.50%222241
    2024-03-31904336523472.18%242235
    2023-12-31843844016666.38%202827
    2023-09-30754318588474.57%252321
    2023-06-30692465530060.10%81438
    2023-03-31662607645063.56%81829
    2022-12-31692710267466.06%191925
    2022-09-30622750791367.92%151723
    dateorgNametotalratiochangeShareschangeRatio
    2024-03-31Ra Capital Management, L.P.1493206324.85%0
    2024-03-31Sands Capital Ventures, Llc34170755.69%0
    2024-03-31Franklin Resources Inc33954185.65%366091.09%
    2024-03-31Millennium Management Llc26295414.38%113425775.86%
    2024-03-31Rock Springs Capital Management Lp23000593.83%0
    2024-03-31Fmr Llc20890003.48%2089000
    2024-03-31Laurion Capital Management Lp18950233.15%0
    2024-03-31Vanguard Group Inc16650582.77%-174494-9.49%
    2024-03-31Knollwood Investment Advisory, Llc16285102.71%0
    2024-03-31Price T Rowe Associates Inc /Md/10982761.83%1098276

    About

    Acumen Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company, which discovers and develops medicines and diagnostics for Alzheimer's disease. The company was founded by William L. Klein, Grant A. Krafft, and Caleb Finch in 1996 and is headquartered in Charlottesville, VA.
    Address:427 Park Street

    Market Movers